» Articles » PMID: 5149097

Treatment of Hypertension with Propranolol and Hydralazine

Overview
Journal Acta Med Scand
Specialty General Medicine
Date 1971 Dec 1
PMID 5149097
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.

van der Veur E, TEN BERGE B, Donker A, May J, Wesseling H Eur J Clin Pharmacol. 1982; 21(6):457-60.

PMID: 7042373 DOI: 10.1007/BF00542038.


Hydralazine, antinuclear antibodies, and the lupus syndrome.

Harland S, Ryan P, Bernstein R, Dollery C, Hughes G, Bulpitt C Br Med J (Clin Res Ed). 1982; 284(6320):936-9.

PMID: 6802356 PMC: 1496454. DOI: 10.1136/bmj.284.6320.936.


Beta-adrenergic receptor blocking drugs in hypertension.

Simpson F Drugs. 1974; 7(1):85-105.

PMID: 4152167 DOI: 10.2165/00003495-197407010-00006.


Cadralazine versus prazosin as second-step treatment in hypertensive patients on beta-blockers: a randomized multicentre study. The Italian Multicentre Study Group.

Caponnetto S, Valvo E, Mocarelli P, Alberti D, Savonitto S Eur J Clin Pharmacol. 1991; 40(5):461-5.

PMID: 1679390 DOI: 10.1007/BF00315223.


Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.

Persson I Eur J Clin Pharmacol. 1975; 9(2-3):91-3.

PMID: 786690 DOI: 10.1007/BF00614002.